+86-2988253271

Egg Lecithin in Softgel Manufacturing: Compatibility And Processing Considerations

Aug 28, 2026

Natural egg yolk lecithin is a natural phospholipid complex extracted from egg yolks and is widely used as an egg phospholipid ingredient in nutraceutical and pharmaceutical formulations. Its principal components include phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidic acid (PA). In soft capsule manufacturing, pure egg yolk lecithin powder can function as both a nutraceutical ingredient and a pharmaceutical excipient. Its physicochemical properties support formulation development and help regulate the characteristics of soft capsule systems. For manufacturers seeking natural egg lecithin, bulk supply, or specialized egg lecithin for soft capsules, quality specifications and application requirements should guide ingredient selection.

Egg Lecithin Softgel

Physicochemical Properties and Functional Positioning of Egg Yolk Lecithin

Physicochemical Properties

• Chemical Composition:

Egg yolk lecithin typically contains 60%–80% phosphatidylcholine (PC) and 12%–20% phosphatidylethanolamine (PE). Its fatty acids include saturated fatty acids such as palmitic and stearic acids and unsaturated fatty acids such as oleic, linoleic, arachidonic acid (ARA), and DHA. Compared with soybean lecithin, egg lecithin contains relatively higher ARA and DHA levels and is naturally soy-free.

• Solubility and Dispersibility:

As an amphiphilic phospholipid, egg yolk lecithin contains a hydrophilic phosphocholine head and lipophilic fatty acid tails. It has limited water solubility but can form liposomes or micelles in aqueous systems. It also shows good compatibility and dispersibility in lipid matrices, including fish oil, vegetable oils, and medium-chain triglycerides (MCT).

• Heat and Oxygen Sensitivity:

Because of its unsaturated fatty acid content, natural egg lecithin can be sensitive to heat, light, and oxygen. Excessive heating may promote degradation and changes in color or acid value, while oxygen exposure can accelerate lipid oxidation and peroxide formation. Appropriate packaging and storage conditions are therefore important for maintaining product quality.

 

Main Functions in Soft Capsules

• Solubilization and Emulsification:

Egg yolk lecithin for soft capsules functions as a natural emulsifier that can reduce oil-water interfacial tension. It promotes uniform dispersion of poorly water-soluble active ingredients and nutrients within oily formulations.

• Anti-Crystallization and Suspension Stabilization:

In suspension soft capsules, egg phospholipids can adsorb onto solid particles, helping reduce particle aggregation, crystal growth, and sedimentation. This contributes to improved physical stability and content uniformity.

• Potential Bioavailability Enhancement:

Due to its amphiphilic structure and similarity to biological membrane phospholipids, egg lecithin can support the formation of mixed micelles during digestion, potentially facilitating the absorption and transport of lipid-soluble nutrients.

• Lubrication and Flowability:

Egg yolk lecithin may also improve the flow characteristics of capsule contents, reduce adhesion, and support more consistent filling during softgel manufacturing. For manufacturers seeking bulk egg yolk lecithin, selecting a reliable egg lecithin supplier with consistent PC/PE specifications and quality control is essential.

 

Compatibility of Egg Yolk Lecithin with Soft Capsule System Components

In soft capsule manufacturing, the system generally consists of two main parts: the capsule shell and the fill material. Adding egg yolk lecithin can influence the physical and interfacial properties of the formulation, so its compatibility with other components should be evaluated during product development.

bulk egg yolk lecithin

Compatibility with Soft Capsule Shell Components

Soft capsule shells are commonly composed of gelatin or plant-based materials such as modified starch and carrageenan, together with plasticizers such as glycerol or sorbitol and a controlled amount of water. The shell's moisture content is typically maintained within a specific range to preserve its mechanical properties.

Water migration: Egg lecithin may interact with moisture within the formulation. If the fill contains a high concentration of egg phospholipids and free water is not adequately controlled, moisture migration between the fill and capsule shell may occur. Excessive water loss from the shell can contribute to hardening or brittleness, while moisture entering the fill may promote lecithin hydration and increase viscosity.

Plasticizer interactions: Small-molecule plasticizers such as glycerol may migrate in trace amounts between the shell and fill under certain conditions. The polar groups of egg yolk lecithin can interact with glycerol without necessarily causing chemical incompatibility. However, formulation developers should evaluate whether high plasticizer levels affect the organization of lecithin phospholipid structures.

Gelatin crosslinking risk: Egg yolk lecithin contains phospholipids, including phosphatidylethanolamine (PE), which has primary amino groups. If aldehyde impurities or oxidation products are present, interactions with gelatin may become possible. Under appropriate storage conditions, however, egg yolk lecithin powder itself is not expected to directly cause significant gelatin crosslinking.

Compatibility with Soft Capsule Fill Materials

Soft capsule fills can generally be categorized as solutions, suspensions, or self-emulsifying systems. The compatibility of egg lecithin for soft capsules depends strongly on the polarity and composition of the fill matrix.

Lipophilic solvents: Egg yolk lecithin generally shows good compatibility with lipid-based carriers such as MCT oil, soybean oil, and sunflower oil. In anhydrous, high-fat systems, phospholipid molecules can organize into structures that support good dispersion and formulation stability.

Hydrophilic solvents: In formulations containing PEG 400 or other relatively polar excipients, lecithin solubility may decrease as polarity increases. Excessive PEG concentrations may therefore contribute to precipitation or phase separation. Compatibility testing is recommended before using high levels of egg yolk lecithin in highly polar matrices.

Suspended solid particles: In suspension-type fills containing vitamin C, plant extracts, or other powders, lecithin may adsorb onto particle surfaces and influence dispersion characteristics. Long-term stability studies should monitor aggregation, sedimentation, crystal growth, viscosity changes, and phase separation.

Egg Lecithin Compatibility Assessment And Experimental Parameters

Evaluation Dimensions:

Test Items

Criteria for good compatibility:

Incompatibility Manifestations and Causes:

Interaction between capsule shell and contents

Capsule skin disintegration time, degree of disintegration, and hardness test

Disintegration time ≤ 15 minutes; no hardening or softening of the capsule shell and leakage.

* Excessive disintegration (cross-linking reaction); softening and leakage of the capsule shell (hygroscopic or oil migration);

Physical compatibility (contents)

Separation rate and centrifugal stability (3000 rpm/30 min)

No phase separation, no precipitation, clear interface without turbidity rings.

* Flocculation, stratification, or flocculent precipitation (reverse micelle destruction);

Chemical compatibility (active ingredient)

HPLC drug content, peroxide value (POV), and acid value (AV)

Change in active pharmaceutical ingredient content < 5%; increases in POV and AV meet limits.

* Degradation of active ingredients, oxidative deterioration of lecithin (peroxide catalysis);

Appearance and rheology

Color change and viscosity change curve (shear rate)

No significant darkening of color (ΔE < 2.0); stable viscosity.

* Significant blackening or yellowing (Maillard reaction);

 

Preparation Process and Precautions for Egg Yolk Lecithin Soft Capsules

Soft capsule production typically involves content formulation, gelatin shell preparation, rotary-die encapsulation, washing, drying, and packaging. The physical and chemical properties of egg yolk lecithin, including its viscosity, dispersibility, and oxidation sensitivity, directly affect processing parameters and finished-product quality. Therefore, manufacturers using egg lecithin for supplements should carefully control temperature, mixing, filling, sealing, and drying conditions throughout the production process.

Content Formulation and Ingredient Processing

• Ingredient Addition Sequence and Dispersion:

When preparing suspension- or emulsion-type contents containing egg yolk phospholipids, the carrier oil, such as medium-chain triglycerides (MCT), should first be heated to approximately 40–50°C. Egg yolk lecithin powder can then be added slowly while stirring until it is fully dispersed, dissolved, or swollen. Active pharmaceutical ingredients and other formulation components should be incorporated afterward. Directly adding lecithin to cold oil or an aqueous phase should be avoided because it may cause agglomeration and uneven dispersion.

• Shear and Homogenization:

After natural egg lecithin has been incorporated into the oil phase, formulations containing insoluble particles may require high-shear homogenization or a colloid mill. A homogenization speed of approximately 3,000–5,000 rpm may be used as a process reference, while excessive processing should be avoided to prevent unnecessary temperature increases. The specific parameters should be validated according to the formulation and equipment.

• Temperature Control:

Egg lecithin is sensitive to oxidation and may undergo discoloration under excessive heat. During preparation, the process temperature should generally be controlled within approximately 40–55°C. Prolonged exposure to temperatures above 60°C should be avoided to help maintain the quality and stability of egg phospholipids.

• Vacuum Degassing:

After homogenization, vacuum degassing can be used to remove entrapped air. A vacuum level of approximately 0.08–0.095 MPa may serve as a process reference. Residual air bubbles can negatively affect filling uniformity and may increase exposure of egg yolk lecithin to oxygen, potentially accelerating oxidation.

Filling and Sealing Control

• Viscosity and Pumpability:

The viscosity of the filling material directly affects metering accuracy during encapsulation. For formulations containing egg yolk lecithin, the filling viscosity should be established and validated according to the equipment and formulation. Excessive lecithin addition may substantially increase viscosity. If necessary, manufacturers may optimize the formulation or adjust the filling temperature within the validated processing range.

• Wedge Temperature:

During rotary-die encapsulation, the wedge temperature must be matched to the filling characteristics and sealing requirements of the formulation. Excessive temperature should be avoided because it may negatively affect heat-sensitive components. Proper temperature matching helps prevent condensation, filling instability, and oil migration into the capsule seam.

• Capsule Thickness and Seal Strength:

Residual egg lecithin soft capsule filling material at the sealing area can reduce seal integrity. Therefore, die-roll pressure and other encapsulation parameters should be appropriately adjusted and validated to ensure consistent sealing strength and minimize leakage or defective capsules.

Drying and Post-Processing

• Rotary Drying:

Immediately after encapsulation, soft capsules typically undergo initial drying in a rotating drum. A controlled environment of approximately 20–24°C and 20–30% relative humidity (RH) can be used as a process reference. At this stage, the capsules remain relatively soft and may have an oily surface, so excessive mechanical impact should be avoided.

• Tray or Tunnel Drying:

After initial shaping, capsules can be transferred to trays for secondary drying. Because egg yolk lecithin is sensitive to heat and oxidation, moderate drying conditions are preferred. A temperature around 22–25°C may be used as a reference, with drying continued until the capsule shell reaches the required moisture equilibrium. The final moisture specification should be determined according to the capsule shell formulation and validated manufacturing process.

• Solvent Cleaning:

If solvents such as isopropanol or hydrocarbons are used to remove residual liquid paraffin from the capsule surface, manufacturers should evaluate the potential for solvent interaction with the filling material. Cleaning time should be minimized while maintaining adequate surface cleanliness.

Manufacturing Process Key Process Parameters

Processing steps:

Key Process Parameters (CPP)

Recommended control range:

Control Objectives and Potential Risks

Ingredient preparation and dissolution

Ingredient temperature, nitrogen protection

40℃–55℃; Nitrogen purging (residual oxygen < 2%)

Prevent thermal degradation and oxidation of lecithin; excessively high temperatures can lead to darkening of the color.

Homogeneous mixing and dispersion

Homogenizing speed, shearing time

3000–5000 rpm; 15–30 minutes

Ensure solid/oil phase homogeneity; excessive shearing can cause material temperature rise.

Vacuum degassing

Vacuum level, degassing time

0.085 to 0.095 MPa; 45–90 minutes

Eliminate microbubbles; residual bubbles can cause dosage discrepancies and oxidation.

Tableting and filling

Material viscosity, nozzle temperature, seaming pressure

500–3000 mPa・s; 38℃–41℃; Adjust as needed

Ensure accurate dosage and sealing strength; oil trapping can lead to leakage.

Setting and final drying

Ambient temperature for drying, relative humidity (RH)

Temperature 20℃ 25℃; RH 20% 25%

Slow dehydration prevents thermal deformation and oxidation; high temperatures can cause gelatin to melt or lecithin to deteriorate.

 

Quality Control, Stability, and Storage Requirements for Egg Yolk Lecithin

Quality control is essential for maintaining the safety, stability, and consistency of egg yolk lecithin used in nutraceutical and soft capsule formulations. Key quality indicators should be monitored throughout raw material processing and finished-product manufacturing.

Key Quality Indicators

Peroxide Value (POV) and Acid Value (AV): Peroxide value is an important indicator of lipid oxidation. For natural egg yolk lecithin, the POV of raw materials and finished products is recommended to be controlled at ≤5.0 meq/kg. An increased acid value may indicate phospholipid hydrolysis and should be controlled at ≤30 mg KOH/g.

• Residual Solvents:

Ethanol, acetone, or hexane may be used during the extraction and purification of egg lecithin. Residual solvents in finished soft capsules should comply with applicable USP, EP, or ChP requirements, such as hexane ≤290 ppm and ethanol ≤5,000 ppm.

• Microorganisms and Heavy Metals:

Because egg yolk lecithin powder is derived from eggs, manufacturers should conduct strict microbiological testing, including Salmonella, Staphylococcus aureus, and Escherichia coli. Heavy metals, including lead, arsenic, mercury, and cadmium, should also comply with applicable limits.

Packaging and Storage

Nitrogen-Filled Packaging: High-purity nitrogen can be used before sealing aluminum-plastic blister packs or HDPE bottles to reduce oxygen exposure and help protect egg phospholipids from oxidation.

• Light Protection:

Alu-Alu packaging or dark PVDC/PVC composite materials can provide effective light and oxygen barriers, helping maintain egg yolk lecithin stability.

• Storage Conditions:

Store bulk egg yolk lecithin and finished products in a cool, dry environment at 15–25°C with relative humidity below 60%. Avoid direct sunlight, excessive heat, and repeated freeze-thaw cycles. Proper packaging and storage are essential when selecting an egg yolk lecithin supplier for long-term supply.

 

FAQs:

Q1: How does egg yolk lecithin affect softgel fill-shell compatibility during production?

Egg yolk lecithin acts as an excellent natural surfactant that improves compatibility between lipid-based formulations and gelatin shells. Proper dosage ensures the lipophilic mixture stays stable without releasing free fatty acids or excessive moisture, which prevents gelatin softening, leaks, and unwanted structural deformation during storage.

Q2: What viscosity adjustments are required when encapsulating egg yolk lecithin formulations?

High-purity egg phospholipids increase fill viscosity, necessitating strict temperature regulation during mixing and injection. Standard processing requires warming the lipid carrier to maintain pumpability without exceeding thermal limits. Controlled flow guarantees uniform weight, consistent dosage precision, and smooth ribbon filling during rotary-die encapsulation.

Q3: Can egg lecithin cause gelatin cross-linking in soft capsule shells?

Raw or unrefined egg lecithin may contain reactive aldehydes or peroxides that trigger gelatin cross-linking, resulting in brittle shells and reduced dissolution rates. Manufacturers must select pharmaceutical-grade egg phospholipids with low peroxide values to maintain elasticity, prolong shelf life, and preserve rapid capsule disintegration.

Q4: Why select egg yolk lecithin over soy or sunflower lecithin for softgels?

Egg lecithin offers a unique phosphatidylcholine and sphingomyelin profile, enhancing the bioavailability of sensitive active pharmaceutical ingredients. Its high purity, clean flavor profile, and hypoallergenic status relative to soy make it the preferred emulsification properties excipient for high-end nutritional and pharmaceutical softgel products.

Q5: What processing temperatures are recommended for egg lecithin fill preparation?

Processing temperatures for egg lecithin suspensions should ideally remain between 35°C and 45°C. Excessive heat degrades delicate phospholipids and oxidizes unsaturated lipids, while low temperatures cause excessive viscosity. Maintaining this optimal range ensures homogeneous mixing, smooth machine pumping, and reliable softgel seam seals.

Q6: How does egg lecithin prevent phase separation in liquid softgel fills?

As a potent amphiphilic emulsifier, egg yolk lecithin reduces interfacial tension between oil-soluble active ingredients and minor hydrophilic additives. It creates a stable, homogeneous dispersion, preventing phase separation during hold times and guaranteeing that every encapsulated softgel delivers an exact, uniform active ingredient dose.

Q7: What moisture controls are critical when processing egg yolk lecithin softgels?

Egg lecithin is highly hygroscopic and can draw water from the gelatin shell into the core formulation if unmonitored. Operators must strictly regulate relative humidity in encapsulation rooms and maintain fill moisture content below 1% to prevent capsule sticky residue, seal failure, or shell collapse.

Q8: How does egg lecithin influence post-encapsulation softgel drying dynamics?

Egg lecithin fill formulations alter water migration rates from the gelatin ribbon during drying. Because the phospholipids stabilize the inner shell interface, softgels require precisely controlled tumble drying and tray dehumidification cycles to achieve target shell hardness without causing physical deformation or seam weakness.

Q9:How To Choose egg lecithin for softgel supplements?

Select pharmaceutical-grade egg lecithin with high phosphatidylcholine content, low peroxide values, and minimal moisture. Verify strict heavy metal testing, uniform particle size for fill stability, and proven compatibility with gelatin shells to prevent cross-linking, seal failures, or oxidation, ensuring maximum bioactivity and softgel shelf life.

 

Conclusion:

In softgel manufacturing, egg yolk lecithin functions as both a high-value nutraceutical ingredient and a versatile functional excipient. Sourcing from a specialized egg yolk lecithin supplier like Guanjie Biotech guarantees high-purity phosphatidylcholine to enhance formulation stability, solubilize actives, and prevent particle aggregation. However, manufacturers must optimize processing parameters-controlling fill-shell compatibility, moisture migration, temperature ranges (40–55°C), and drying dynamics-to prevent phospholipid oxidation while ensuring long-term capsule integrity and maximum bioavailability. Welcome to enquire with us at info@gybiotech.com.

 

References

[1] Hou, X. L., Qiao, X. G., Du, J. M., & Wang, G. F. (2005). Egg yolk lecithin soft capsule and its production process. Chinese Patent No. CN1212843C. Institute of Coal Chemistry, Chinese Academy of Sciences. (Priority date: 2003)

[2]Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene. (2018). US Patent Application No. US20190091157A1. (Discloses softgel manufacturing processes, gelatin shell composition, and filling viscosity control parameters)

[3]Lipid-Based Formulation Classification System. (n.d.). Bioavailability.com. (Provides excipient compatibility reference for lipid-based softgel formulations)

[4]Hou Xianglin, Qiao Xingang, Du Junmin, Wang Guofu. (2005). Egg yolk lecithin soft capsules and their production process. Chinese Invention Patent, CN1212843C. Shanxi Coal Chemistry Institute, Chinese Academy of Sciences.

[5]Egg yolk lecithin soft capsules and their production process. (2004). Chinese Invention Patent, CN1475216A. Shanxi Coal Chemistry Institute, Chinese Academy of Sciences.

[6]Preparation, detection and experimental study of egg yolk lecithin and its effect on improving memory function. (2009). Master's thesis, Jilin University. (Systematically studied the extraction process of egg yolk lecithin and the technical parameters for soft capsule preparation)

[7]Processing method of compound egg yolk lecithin soft capsule nutritional health food. (2002). Chinese Invention Patent. (Discloses the ethanol extraction, supercritical CO₂extraction and soft capsule preparation process of egg yolk lecithin)

[8]Method for preparing egg-yolk lecithin. (2007). Chinese Invention Patent, CN101029057A. (The preparation process of egg yolk lecithin and the soft capsule pressing process were disclosed, indicating that the temperature was controlled below 50℃ throughout the process to ensure bioactivity.)

Send Inquiry